83 FR 47927 - Center for Scientific Review; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 184 (September 21, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 184 (September 21, 2018)
| Page Range | 47927-47929 | |
| FR Document | 2018-20520 |
[Federal Register Volume 83, Number 184 (Friday, September 21, 2018)] [Notices] [Pages 47927-47929] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-20520] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Evaluation and Implementation of Patient Care. Date: October 11, 2018. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Capital Skyline Hotel, 10 I Street SW, Washington, DC 20024. Contact Person: Gabriel B. Fosu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3108, MSC 7808, Bethesda, MD 20892, (301) 435-3562, fosug@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Academic-Industrial Partnerships Research for Cancer Diagnosis and Treatment. Date: October 15-16, 2018. Time: 8:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. [[Page 47928]] Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, 301-237- 9870, xuguofen@csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genetic Variation and Evolution Study Section. Date: October 15-16, 2018. Time: 8:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn San Diego Downtown Bayfront, 900 Bayfront Court, San Diego, CA 92104. Contact Person: Cheryl M. Corsaro, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD 20892, (301) 435-1045, corsaroc@csr.nih.gov. Name of Committee: Biobehavioral and Behavioral Processes Integrated Review Group; Child Psychopathology and Developmental Disabilities Study Section. Date: October 18-19, 2018. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 22102. Contact Person: Katherine Colona Morasch, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, moraschkc@csr.nih.gov. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group; Integrative and Clinical Endocrinology and Reproduction Study Section. Date: October 18, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard by Marriott Silver Spring, 8506 Fenton Street, Silver Spring, MD 20910. Contact Person: Dianne Hardy, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6175, MSC 7892, Bethesda, MD 20892, 301-435- 1154, dianne.hardy@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Surgical Disparities Research. Date: October 19, 2018. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Palomar, 2121 P Street NW, Washington, DC 20037. Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3139, Bethesda, MD 20892, 301- 827-3689, fergusonyo@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR18-721: Counter Act Exploratory Grants. Date: October 19, 2018. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Lord Baltimore Hotel, 20 West Baltimore Street, Baltimore, MD 21201. Contact Person: Geoffrey G. Schofield, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4040-A, MSC 7850, Bethesda, MD 20892, 301-435-1235, geoffreys@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Medical Imaging Investigations. Date: October 19, 2018. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Guo Feng Xu, Ph.D., Scientific Review Office, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, 301-237- 9870, xuguofen@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR 18-039: Intellectual and Developmental Disabilities Outcomes. Date: October 19, 2018. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 22102. Contact Person: Katherine Colona Morasch, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3170, Bethesda, Md 20892, moraschkc@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Ocular Surface, Cornea, Anterior Segment Glaucoma and Refractive Error. Date: October 22-23, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Beacon Hotel and Corporate Quarters, 1615 Rhode Island Avenue NW, Washington, DC 20036. Contact Person: Kristin Kramer, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5205, MSC 7846, Bethesda, MD 20892, (301) 437-0911, kramerkm@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Virology--A Study Section, Date: October 22-23, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Westin Crystal City, 1800 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Kenneth M Izumi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3204, MSC 7808, Bethesda, MD 20892, 301-496-6980, izumikm@csr.nih.gov. Name of Committee: Oncology 1--Basic Translational Integrated Review Group; Tumor Microenvironment Study Section. Date: October 22-23, 2018. Time: 8:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 22102. Contact Person: Angela Y. Ng, Ph.D., MBA, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6200, MSC 7804, Bethesda, MD 20892, 301-435-1715, ngan@mail.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Membrane Biology and Protein Processing Study Section. Date: October 22-23, 2018. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Janet M. Larkin, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5142, MSC 7840, Bethesda, MD 20892, 301-806-2765, larkinja@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Aging Systems and Geriatrics Study Section. Date: October 22-23, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Inese Z. Beitins, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6152, MSC 7892, Bethesda, MD 20892, 301-435- 1034, beitinsi@csr.nih.gov. Name of Committee: Oncology 1--Basic Translational Integrated Review Group; Cancer Genetics Study Section. Date: October 22-23, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bahia Resort Hotel, 998 West Mission Bay Drive, San Diego, CA 92109. Contact Person: Juraj Bies, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 20892, 301-435- 1256, biesj@mail.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Virology--B Study Section. Date: October 22-23, 2018. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Alexandrian, 480 King Street, Alexandria, VA 22314. Contact Person: John C. Pugh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435- 2398, pughjohn@csr.nih.gov. Name of Committee: Vascular and Hematology Integrated Review Group; [[Page 47929]] Vascular Cell and Molecular Biology Study Section. Date: October 22-23, 2018. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Larry Pinkus, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4132, MSC 7802, Bethesda, MD 20892, (301) 435- 1214, pinkusl@csr.nih.gov. Name of Committee: Biobehavioral and Behavioral Processes Integrated Review Group; Adult Psychopathology and Disorders of Aging Study Section. Date: October 22-23, 2018. Time: 8:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes Street, Arlington, VA 22202. Contact Person: Serena Chu, Ph.D., Scientific Review Officer, BBBP IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD 20892, (301) 500-5829, sechu@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Risk Prevention and Health Behavior AREA Review. Date: October 22, 2018. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: John H. Newman, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD 20892, (301) 435-0628, newmanjh@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Psychosocial Risks and Disease Prevention. Date: October 22, 2018. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Weijia Ni, Ph.D., Chief/Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD 20892, 301-594-3292, niw@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 17, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-20520 Filed 9-20-18; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 83, No. 184 / Friday, September 21, 2018 / Notices 47927
submission. You should submit two Avenue, Bldg. 32, Rm. 5172, Silver You can use an alternative approach if
copies total. One copy will include the Spring, MD 20993–0002, 301–796–2941. it satisfies the requirements of the
information you claim to be confidential SUPPLEMENTARY INFORMATION: applicable statutes and regulations. This
with a heading or cover note that states guidance is not subject to Executive
‘‘THIS DOCUMENT CONTAINS I. Background Order 12866.
CONFIDENTIAL INFORMATION.’’ The FDA is announcing the availability of II. Electronic Access
Agency will review this copy, including a draft guidance for industry entitled
the claimed confidential information, in ‘‘Civil Money Penalties Relating to the Persons with access to the internet
its consideration of comments. The ClinicalTrials.gov Data Bank; Draft may obtain the draft guidance at either
second copy, which will have the Guidance for FDA Staff, Responsible https://www.fda.gov/Drugs/Guidance
claimed confidential information Parties, and Submitters of Certain ComplianceRegulatoryInformation/
redacted/blacked out, will be available Applications and Submissions to FDA.’’ Guidances/default.htm or https://
for public viewing and posted on The draft guidance provides the current www.regulations.gov.
https://www.regulations.gov. Submit thinking of FDA’s CDER, CBER, and Dated: September 17, 2018.
both copies to the Dockets Management CDRH (Center, or collectively Centers), Leslie Kux,
Staff. If you do not wish your name and regarding civil money penalties for Associate Commissioner for Policy.
contact information to be made publicly responsible parties and/or submitters of [FR Doc. 2018–20560 Filed 9–20–18; 8:45 am]
available, you can provide this certain applications and submissions to BILLING CODE 4164–01–P
information on the cover sheet and not FDA regarding drug products, biological
in the body of your comments and you products, or device products
must identify this information as (submitters) who violate applicable DEPARTMENT OF HEALTH AND
‘‘confidential.’’ Any information marked FD&C Act (21 U.S.C. 301 et seq.) HUMAN SERVICES
as ‘‘confidential’’ will not be disclosed prohibitions relating to requirements
except in accordance with 21 CFR 10.20 under section 402(j) of the Public Health National Institutes of Health
and other applicable disclosure law. For Service Act (PHS Act) (42 U.S.C. 282(j)),
more information about FDA’s posting including its implementing regulations Center for Scientific Review; Notice of
of comments to public dockets, see 80 in 42 CFR part 11, to submit registration Closed Meetings
FR 56469, September 18, 2015, or access and/or results information to the Pursuant to section 10(d) of the
the information at: https://www.gpo.gov/ ClinicalTrials.gov data bank and/or Federal Advisory Committee Act, as
fdsys/pkg/FR-2015-09-18/pdf/2015- certain certifications to FDA. The draft amended, notice is hereby given of the
23389.pdf. guidance is intended to address several following meetings.
Docket: For access to the docket to questions. First, how the Centers The meetings will be closed to the
read background documents or the identify whether responsible parties public in accordance with the
electronic and written/paper comments have failed to submit required clinical provisions set forth in sections
received, go to https:// trial registration and/or results 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
www.regulations.gov and insert the information to the ClinicalTrials.gov as amended. The grant applications and
docket number, found in brackets in the data bank or submitted false or the discussions could disclose
heading of this document, into the misleading information to the data bank, confidential trade secrets or commercial
‘‘Search’’ box and follow the prompts and whether submitters have failed to property such as patentable material,
and/or go to the Dockets Management submit the certification required by and personal information concerning
Staff, 5630 Fishers Lane, Rm. 1061, section 402(j)(5)(B) of the PHS Act (42 individuals associated with the grant
Rockville, MD 20852. U.S.C. 282(j)(5)(B)) to FDA or knowingly applications, the disclosure of which
You may submit comments on any submitted a false certification to FDA. would constitute a clearly unwarranted
guidance at any time (see 21 CFR Second, under what circumstances a invasion of personal privacy.
10.115(g)(5)). Center may decide to seek civil money Name of Committee: Center for Scientific
penalties against a responsible party or Review Special Emphasis Panel; Evaluation
Submit written requests for single submitter. Third, what procedures apply
copies of the draft guidance to the and Implementation of Patient Care.
when a Center seeks civil money Date: October 11, 2018.
Division of Drug Information, Center for penalties; and finally, what civil money Time: 10:00 a.m. to 12:00 p.m.
Drug Evaluation and Research, Food penalty amounts may be assessed for: Agenda: To review and evaluate grant
and Drug Administration, 10001 New (1) Failing to submit required clinical applications.
Hampshire Ave., Hillandale Building, trial registration and/or results Place: Capital Skyline Hotel, 10 I Street
4th Floor, Silver Spring, MD 20993– information to the ClinicalTrials.gov SW, Washington, DC 20024.
0002, or the Office of Communication, Contact Person: Gabriel B. Fosu, Ph.D.,
data bank, (2) knowingly submitting Scientific Review Officer, Center for
Outreach and Development, Center for false or misleading clinical trial
Biologics Evaluation and Research, Scientific Review, National Institutes of
information to the data bank, (3) failing Health, 6701 Rockledge Drive, Room 3108,
Food and Drug Administration, 10903 to submit the required certification to MSC 7808, Bethesda, MD 20892, (301) 435–
New Hampshire Ave., Bldg. 71, Rm. FDA, or (4) knowingly submitting a false 3562, fosug@csr.nih.gov.
3128, Silver Spring, MD 20993–0002. certification to FDA. Name of Committee: Center for Scientific
Send one self-addressed adhesive label This draft guidance is being issued Review Special Emphasis Panel; PAR Panel:
to assist that office in processing your consistent with FDA’s good guidance Academic-Industrial Partnerships Research
daltland on DSKBBV9HB2PROD with NOTICES
requests. See the SUPPLEMENTARY practices regulation (21 CFR 10.115). for Cancer Diagnosis and Treatment.
INFORMATION section for electronic Date: October 15–16, 2018.
The draft guidance, when finalized, will
access to the draft guidance document. represent the current thinking of FDA
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
FOR FURTHER INFORMATION CONTACT: on civil money penalties relating to the applications.
Patrick McNeilly, Office of Good ClinicalTrials.gov data bank. It does not Place: Hyatt Regency Bethesda, One
Clinical Practice, Food and Drug establish any rights for any person and Bethesda Metro Center, 7400 Wisconsin
Administration, 10903 New Hampshire is not binding on FDA or the public. Avenue, Bethesda, MD 20814.
VerDate Sep<11>2014 17:30 Sep 20, 2018 Jkt 244001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\21SEN1.SGM 21SEN1](https://thefederalregister.org/doc/83_FR_48111/page/1.svg)
![Federal Register / Vol. 83, No. 184 / Friday, September 21, 2018 / Notices 47929
Vascular Cell and Molecular Biology Study Dated: September 17, 2018. Agenda: To review and evaluate grant
Section. Sylvia L. Neal, applications.
Date: October 22–23, 2018. Place: Warwick Denver, 1776 Grant Street,
Program Analyst, Office of Federal Advisory
Time: 8:30 a.m. to 5:00 p.m. Denver, CO 80203.
Committee Policy.
Agenda: To review and evaluate grant Contact Person: Fouad A. El-Zaatari, Ph.D.,
[FR Doc. 2018–20520 Filed 9–20–18; 8:45 am] Scientific Review Officer, Center for
applications.
Place: Hyatt Regency Bethesda, One BILLING CODE 4140–01–P Scientific Review, National Institutes of
Bethesda Metro Center, 7400 Wisconsin Health, 6701 Rockledge Drive, Room 3186,
MSC 7808, Bethesda, MD 20892, (301) 435–
Avenue, Bethesda, MD 20814.
DEPARTMENT OF HEALTH AND 1149, elzaataf@csr.nih.gov.
Contact Person: Larry Pinkus, Ph.D.,
Scientific Review Officer, Center for HUMAN SERVICES Name of Committee: Musculoskeletal, Oral
Scientific Review, National Institutes of and Skin Sciences Integrated Review Group;
Health, 6701 Rockledge Drive, Room 4132, National Institutes of Health Oral, Dental and Craniofacial Sciences Study
Section.
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, pinkusl@csr.nih.gov.
Center for Scientific Review; Notice of Date: October 18–19, 2018.
Closed Meetings Time: 8:00 a.m. to 12:00 p.m.
Name of Committee: Biobehavioral and Agenda: To review and evaluate grant
Behavioral Processes Integrated Review Pursuant to section 10(d) of the applications.
Group; Adult Psychopathology and Disorders Federal Advisory Committee Act, as Place: Residence Inn Capital View, 2850
of Aging Study Section. amended, notice is hereby given of the South Potomac Avenue, Arlington, VA
Date: October 22–23, 2018. following meetings. 22202.
Time: 8:30 a.m. to 3:00 p.m. Contact Person: Yi-Hsin Liu, Ph.D.,
The meetings will be closed to the
Agenda: To review and evaluate grant Scientific Review Officer, Center for
public in accordance with the Scientific Review, National Institutes of
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
provisions set forth in sections Health, 6701 Rockledge Drive, Room 4214,
1250 South Hayes Street, Arlington, VA 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., MSC 7814, Bethesda, MD 20892, 301–435–
22202. as amended. The grant applications and 1781, liuyh@csr.nih.gov.
Contact Person: Serena Chu, Ph.D., the discussions could disclose Name of Committee: Center for Scientific
Scientific Review Officer, BBBP IRG, Center confidential trade secrets or commercial Review Special Emphasis Panel;
for Scientific Review, National Institutes of property such as patentable material, Fellowships: Neurodevelopment, Synaptic
Health, 6701 Rockledge Drive, Room 3178, and personal information concerning Plasticity and Neurodegeneration.
MSC 7848, Bethesda, MD 20892, (301) 500– individuals associated with the grant Date: October 18–19, 2018.
5829, sechu@csr.nih.gov. applications, the disclosure of which Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
Name of Committee: Center for Scientific would constitute a clearly unwarranted
applications.
Review Special Emphasis Panel; Risk invasion of personal privacy. Place: Doubletree Hotel Bethesda
Prevention and Health Behavior AREA Name of Committee: Bioengineering (Formerly Holiday Inn Select), 8120
Review. Sciences & Technologies Integrated Review Wisconsin Avenue, Bethesda, MD 20814.
Date: October 22, 2018. Group; Modeling and Analysis of Biological Contact Person: Mary Schueler, Ph.D.,
Time: 11:00 a.m. to 5:00 p.m. Systems Study Section. Scientific Review Officer, Center for
Agenda: To review and evaluate grant Date: October 18–19, 2018. Scientific Review, National Institutes of
applications. Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 5214,
Place: National Institutes of Health, 6701 Agenda: To review and evaluate grant MSC 7846, Bethesda, MD 20892, 301–451–
Rockledge Drive, Bethesda, MD 20892 applications. 0996, marygs@csr.nih.gov.
(Virtual Meeting). Place: The William F. Bolger Center, 9600 Name of Committee: Center for Scientific
Contact Person: John H. Newman, Ph.D., Newbridge Drive, Potomac, MD 20854. Review Special Emphasis Panel; Fellowship:
Scientific Review Officer, Center for Contact Person: Craig Giroux, Ph.D., Behavioral Neuroscience.
Scientific Review, National Institutes of Scientific Review Officer, BST IRG, Center Date: October 18–19, 2018.
Health, 6701 Rockledge Drive, Room 3222, for Scientific Review, National Institutes of Time: 8:00 a.m. to 5:00 p.m.
MSC 7808, Bethesda, MD 20892, (301) 435– Health, 6701 Rockledge Drive, Room 5150, Agenda: To review and evaluate grant
0628, newmanjh@csr.nih.gov. Bethesda, MD 20892, 301–435–2204, applications.
girouxcn@csr.nih.gov. Place: Embassy Suites DC Convention
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member Name of Committee: Vascular and Center, 900 10th Street NW, Washington, DC
Conflict: Psychosocial Risks and Disease Hematology Integrated Review Group; 20001.
Prevention. Hemostasis and Thrombosis Study Section. Contact Person: Mei Qin, MD, Ph.D.,
Date: October 22, 2018. Date: October 18, 2018. Scientific Review Officer, Center for
Time: 12:00 p.m. to 3:00 p.m. Time: 8:00 a.m. to 6:00 p.m. Scientific Review, National Institutes of
Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 5213,
Agenda: To review and evaluate grant
applications. Bethesda, MD 20892, 301–875–2215,
applications.
Place: Hyatt Regency Bethesda, One qinmei@csr.nih.gov.
Place: National Institutes of Health, 6701
Bethesda Metro Center, 7400 Wisconsin Name of Committee: Center for Scientific
Rockledge Drive, Bethesda, MD 20892 Avenue, Bethesda, MD 20814.
(Telephone Conference Call). Review Special Emphasis Panel;
Contact Person: Bukhtiar H. Shah, DVM, Fellowships: Biophysical, Physiological,
Contact Person: Weijia Ni, Ph.D., Chief/ Ph.D., Scientific Review Officer, Vascular Pharmacological and Bioengineering
Scientific Review Officer, Center for and Hematology IRG, Center for Scientific Neuroscience.
Scientific Review, National Institutes of Review, National Institutes of Health, 6701 Date: October 18–19, 2018.
Health, 6701 Rockledge Drive, Room 3100, Rockledge Drive, Room 4120, MSC 7802, Time: 8:00 a.m. to 5:00 p.m.
MSC 7808, Bethesda, MD 20892, 301–594–
daltland on DSKBBV9HB2PROD with NOTICES
Bethesda, MD 20892, (301) 806–7314, Agenda: To review and evaluate grant
3292, niw@csr.nih.gov. shahb@csr.nih.gov. applications.
(Catalogue of Federal Domestic Assistance Name of Committee: Infectious Diseases Place: Doubletree Hotel Bethesda
Program Nos. 93.306, Comparative Medicine; and Microbiology Integrated Review Group; (Formerly Holiday Inn Select), 8120
93.333, Clinical Research, 93.306, 93.333, Host Interactions with Bacterial Pathogens Wisconsin Avenue, Bethesda, MD 20814.
93.337, 93.393–93.396, 93.837–93.844, Study Section. Contact Person: Sussan Paydar, Ph.D.,
93.846–93.878, 93.892, 93.893, National Date: October 18–19, 2018. Scientific Review Officer, Center for
Institutes of Health, HHS) Time: 8:00 a.m. to 3:00 p.m. Scientific Review, National Institutes of
VerDate Sep<11>2014 17:30 Sep 20, 2018 Jkt 244001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\21SEN1.SGM 21SEN1](https://thefederalregister.org/doc/83_FR_48111/page/3.svg)
Document Created: 2018-09-21 00:24:32
Document Modified: 2018-09-21 00:24:32
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | October 11, 2018. | |
| FR Citation | 83 FR 47927 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR